Avian influenza vaccination in Egypt: Limitations of the current strategy
- PMID: 20076791
- PMCID: PMC2805840
- DOI: 10.4172/1747-0862.1000035
Avian influenza vaccination in Egypt: Limitations of the current strategy
Abstract
Vaccination of domestic poultry against avian influenza (AI) has been used on a large-scale in South East Asia since 2003 and in Egypt since 2006 to fight H5N1 highly-pathogenic avian influenza (HPAI) epidemics. The decision to use mass vaccination against HPAI in Egypt was taken as an emergency measure based on positive impact of such control measures in Vietnam and the People's Republic of China. However, three years on, the impact on disease control of AI vaccination in Egypt has been very limited. Despite the continuous vaccination of poultry against HPAI, poultry outbreaks and human cases are reported regularly. A recent assessment study highlighted substantial weaknesses in the current immunisation programme and its lack of positive impact on the spread of infection or the maintenance of public health safety. The shortcomings of the vaccination strategy may be attributed in part to a lack of sufficient support in terms of funding and communication, the absence of an efficient monitoring system, and inadequate training of field technicians. The difficulties of blanket vaccinations in semi-commercial farms and household poultry sectors are well known, however, improvements in the industrial sector should be possible though better government controls and greater collaboration with the private sector. AI vaccination should be regarded as just one control tool within a broader disease control program integrating surveillance, outbreak investigation, disease management systems, and the rigorous implementation of bio-security measures. If incorrectly implemented, AI vaccination has a limited impact as a disease control measure. Moreover, without strict bio-security precautions undertaken during its application, farm visits to vaccinate poultry could facilitate the spread of the virus and therefore become a risk factor with important implications on the maintenance of the virus and potential risk for human exposure.
Keywords: Avian influenza; Egypt; disease control; public health risk; vaccination strategy.
Conflict of interest statement
None declared.
Figures

Similar articles
-
Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.Rev Sci Tech. 2011 Dec;30(3):839-70. doi: 10.20506/rst.30.3.2081. Rev Sci Tech. 2011. PMID: 22435196
-
Impact of vaccines and vaccination on global control of avian influenza.Avian Dis. 2012 Dec;56(4 Suppl):818-28. doi: 10.1637/10183-041012-Review.1. Avian Dis. 2012. PMID: 23402099 Review.
-
Avian influenza A (H5N1) outbreaks in different poultry farm types in Egypt: the effect of vaccination, closing status and farm size.BMC Vet Res. 2018 Jun 18;14(1):187. doi: 10.1186/s12917-018-1519-8. BMC Vet Res. 2018. PMID: 29914481 Free PMC article.
-
Added Value of Avian Influenza (H5) Day-Old Chick Vaccination for Disease Control in Egypt.Avian Dis. 2016 May;60(1 Suppl):245-52. doi: 10.1637/11131-050715-ResNote. Avian Dis. 2016. PMID: 27309063
-
The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine.Avian Pathol. 2002 Feb;31(1):5-12. doi: 10.1080/03079450120106570. Avian Pathol. 2002. PMID: 12430550 Review.
Cited by
-
Creating Disease Resistant Chickens: A Viable Solution to Avian Influenza?Viruses. 2018 Oct 15;10(10):561. doi: 10.3390/v10100561. Viruses. 2018. PMID: 30326625 Free PMC article. Review.
-
Predicting risk of avian influenza a(H5N1) in Egypt: the creation of a community level metric.BMC Public Health. 2018 Mar 21;18(1):388. doi: 10.1186/s12889-018-5288-x. BMC Public Health. 2018. PMID: 29562878 Free PMC article.
-
Analyzing Strategies for Containing Avian Influenza.AMIA Annu Symp Proc. 2023 Apr 29;2022:682-691. eCollection 2022. AMIA Annu Symp Proc. 2023. PMID: 37128393 Free PMC article.
-
Interventions for avian influenza A (H5N1) risk management in live bird market networks.Proc Natl Acad Sci U S A. 2013 May 28;110(22):9177-82. doi: 10.1073/pnas.1220815110. Epub 2013 May 6. Proc Natl Acad Sci U S A. 2013. PMID: 23650388 Free PMC article.
-
The emergence and diversification of panzootic H5N1 influenza viruses.Virus Res. 2013 Dec 5;178(1):35-43. doi: 10.1016/j.virusres.2013.05.012. Epub 2013 Jun 2. Virus Res. 2013. PMID: 23735533 Free PMC article. Review.
References
-
- Busani L, Toson M, Stegeman A, et al. Vaccination reduced the incidence of outbreaks of low pathogenicity avian influenza in northern Italy. Vaccine. 2009;27:3655–3661. - PubMed
-
- Capua I, Schmitz A, Jestin V, Koch G, Marangon S. Vaccination as a tool to combat introductions of notifiable avian influenza viruses in Europe, 2000 to 2006. Rev Sci Tech. 2009;28:245–259. - PubMed
-
- Domenech J, Dauphin G, Rushton J, et al. Experiences with vaccination in countries endemically infected with highly pathogenic avian influenza: the Food and Agriculture Organization perspective. Rev Sci Tech. 2009;28:293–305. - PubMed
-
- Ellis TM, Sims LD, Wong HK, et al. Use of avian influenza vaccination in Hong Kong. Dev Biol (Basel) 2006;124:133–143. - PubMed
LinkOut - more resources
Full Text Sources